HEADER HYDROLASE 12-MAY-03 1P9S TITLE CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE: BASIS FOR DESIGN OF TITLE 2 ANTI-SARS DRUGS COMPND MOL_ID: 1; COMPND 2 MOLECULE: REPLICASE POLYPROTEIN 1AB; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUE 2966-3265, 3C-LIKE PROTEINASE; COMPND 5 SYNONYM: 3CL-PRO; COMPND 6 EC: 3.4.24.-; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN CORONAVIRUS; SOURCE 3 ORGANISM_TAXID: 11137; SOURCE 4 STRAIN: 229E; SOURCE 5 GENE: ORF1A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: TB1; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMAL-MPRO KEYWDS SARS-COV, HCOV, CORONAVIRUS, TGEV, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR K.ANAND,J.ZIEBUHR,P.WADHWANI,J.R.MESTERS,R.HILGENFELD REVDAT 8 30-OCT-24 1P9S 1 REMARK REVDAT 7 15-NOV-23 1P9S 1 REMARK REVDAT 6 16-AUG-23 1P9S 1 REMARK SEQADV LINK REVDAT 5 11-OCT-17 1P9S 1 REMARK REVDAT 4 13-JUL-11 1P9S 1 VERSN REVDAT 3 24-FEB-09 1P9S 1 VERSN REVDAT 2 24-JUN-03 1P9S 1 JRNL REVDAT 1 20-MAY-03 1P9S 0 JRNL AUTH K.ANAND,J.ZIEBUHR,P.WADHWANI,J.R.MESTERS,R.HILGENFELD JRNL TITL CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE: BASIS FOR JRNL TITL 2 DESIGN OF ANTI-SARS DRUGS JRNL REF SCIENCE V. 300 1763 2003 JRNL REFN ISSN 0036-8075 JRNL PMID 12746549 JRNL DOI 10.1126/SCIENCE.1085658 REMARK 2 REMARK 2 RESOLUTION. 2.54 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.54 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 70.71 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 17709 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.279 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 965 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.54 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.61 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1179 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2460 REMARK 3 BIN FREE R VALUE SET COUNT : 57 REMARK 3 BIN FREE R VALUE : 0.3840 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4589 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 12 REMARK 3 SOLVENT ATOMS : 32 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.18000 REMARK 3 B22 (A**2) : -0.91000 REMARK 3 B33 (A**2) : 0.98000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.55000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.371 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.271 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.516 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.922 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.837 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4708 ; 0.020 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 4136 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6371 ; 1.836 ; 1.920 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9601 ; 1.104 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 597 ; 7.547 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 693 ; 0.103 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5367 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 999 ; 0.006 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1045 ; 0.252 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 4900 ; 0.270 ; 0.300 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 2705 ; 0.102 ; 0.500 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 200 ; 0.211 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 14 ; 0.163 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): 48 ; 0.367 ; 0.300 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 8 ; 0.361 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2933 ; 1.343 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4684 ; 2.295 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1775 ; 1.399 ; 2.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1687 ; 2.214 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 1 A 300 4 REMARK 3 1 B 1 B 299 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 4348 ; 0.35 ; 0.50 REMARK 3 MEDIUM THERMAL 1 A (A**2): 4348 ; 0.83 ; 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 1P9S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-MAY-03. REMARK 100 THE DEPOSITION ID IS D_1000019186. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ELETTRA REMARK 200 BEAMLINE : 5.2R REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9801 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17709 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.540 REMARK 200 RESOLUTION RANGE LOW (A) : 70.710 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : 12.30 REMARK 200 R MERGE (I) : 0.14200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1LVO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 10000, 1,6-HEXANEDIOL, DTT, HEPES, REMARK 280 PH 8.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 283K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 38.12000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN B 300 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 136 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 136 CG CD NE CZ NH1 NH2 REMARK 470 VAL B 299 O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O THR B 254 N VAL B 256 1.79 REMARK 500 O THR A 254 N VAL A 256 1.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 19 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ASP A 54 CB - CG - OD2 ANGL. DEV. = 7.1 DEGREES REMARK 500 ASP A 118 CB - CG - OD2 ANGL. DEV. = 6.8 DEGREES REMARK 500 ASP A 186 CB - CG - OD2 ANGL. DEV. = 7.6 DEGREES REMARK 500 ASP B 54 CB - CG - OD2 ANGL. DEV. = 8.2 DEGREES REMARK 500 ASP B 118 CB - CG - OD2 ANGL. DEV. = 6.4 DEGREES REMARK 500 VAL B 127 CB - CA - C ANGL. DEV. = -14.3 DEGREES REMARK 500 ASP B 177 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP B 186 CB - CG - OD2 ANGL. DEV. = 9.4 DEGREES REMARK 500 ASP B 285 CB - CG - OD2 ANGL. DEV. = 7.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 47 41.79 -79.10 REMARK 500 ILE A 140 -155.45 -126.29 REMARK 500 GLN A 234 -9.93 -59.77 REMARK 500 GLU A 244 -46.25 -24.90 REMARK 500 LYS A 253 43.33 -98.70 REMARK 500 THR A 254 -100.44 -2.15 REMARK 500 VAL A 299 -105.68 -51.31 REMARK 500 SER B 107 123.06 -34.50 REMARK 500 TYR B 117 -71.77 -124.38 REMARK 500 ASP B 118 50.40 -99.91 REMARK 500 LYS B 152 130.33 -170.50 REMARK 500 ASN B 242 85.59 -158.37 REMARK 500 GLU B 244 -44.57 -20.82 REMARK 500 THR B 254 -108.69 5.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 VAL A 299 ASN A 300 142.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DIO A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DIO B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1LVO RELATED DB: PDB REMARK 900 TRANSMISSIBLE GASTROENTERITIS VIRUS (TGEV) MAIN PROTEINASE REMARK 900 RELATED ID: 1P9T RELATED DB: PDB REMARK 900 RELATED ID: 1P9U RELATED DB: PDB DBREF 1P9S A 1 300 UNP Q05002 R1AB_CVH22 2966 3265 DBREF 1P9S B 1 300 UNP Q05002 R1AB_CVH22 2966 3265 SEQADV 1P9S MSE A 6 UNP Q05002 MET 2971 MODIFIED RESIDUE SEQADV 1P9S MSE A 60 UNP Q05002 MET 3025 MODIFIED RESIDUE SEQADV 1P9S MSE A 81 UNP Q05002 MET 3046 MODIFIED RESIDUE SEQADV 1P9S MSE A 95 UNP Q05002 MET 3060 MODIFIED RESIDUE SEQADV 1P9S MSE A 129 UNP Q05002 MET 3094 MODIFIED RESIDUE SEQADV 1P9S MSE A 161 UNP Q05002 MET 3126 MODIFIED RESIDUE SEQADV 1P9S MSE A 180 UNP Q05002 MET 3145 MODIFIED RESIDUE SEQADV 1P9S MSE A 198 UNP Q05002 MET 3163 MODIFIED RESIDUE SEQADV 1P9S MSE A 241 UNP Q05002 MET 3206 MODIFIED RESIDUE SEQADV 1P9S MSE A 296 UNP Q05002 MET 3261 MODIFIED RESIDUE SEQADV 1P9S MSE B 6 UNP Q05002 MET 2971 MODIFIED RESIDUE SEQADV 1P9S MSE B 60 UNP Q05002 MET 3025 MODIFIED RESIDUE SEQADV 1P9S MSE B 81 UNP Q05002 MET 3046 MODIFIED RESIDUE SEQADV 1P9S MSE B 95 UNP Q05002 MET 3060 MODIFIED RESIDUE SEQADV 1P9S MSE B 129 UNP Q05002 MET 3094 MODIFIED RESIDUE SEQADV 1P9S MSE B 161 UNP Q05002 MET 3126 MODIFIED RESIDUE SEQADV 1P9S MSE B 180 UNP Q05002 MET 3145 MODIFIED RESIDUE SEQADV 1P9S MSE B 198 UNP Q05002 MET 3163 MODIFIED RESIDUE SEQADV 1P9S MSE B 241 UNP Q05002 MET 3206 MODIFIED RESIDUE SEQADV 1P9S MSE B 296 UNP Q05002 MET 3261 MODIFIED RESIDUE SEQRES 1 A 300 ALA GLY LEU ARG LYS MSE ALA GLN PRO SER GLY PHE VAL SEQRES 2 A 300 GLU LYS CYS VAL VAL ARG VAL CYS TYR GLY ASN THR VAL SEQRES 3 A 300 LEU ASN GLY LEU TRP LEU GLY ASP ILE VAL TYR CYS PRO SEQRES 4 A 300 ARG HIS VAL ILE ALA SER ASN THR THR SER ALA ILE ASP SEQRES 5 A 300 TYR ASP HIS GLU TYR SER ILE MSE ARG LEU HIS ASN PHE SEQRES 6 A 300 SER ILE ILE SER GLY THR ALA PHE LEU GLY VAL VAL GLY SEQRES 7 A 300 ALA THR MSE HIS GLY VAL THR LEU LYS ILE LYS VAL SER SEQRES 8 A 300 GLN THR ASN MSE HIS THR PRO ARG HIS SER PHE ARG THR SEQRES 9 A 300 LEU LYS SER GLY GLU GLY PHE ASN ILE LEU ALA CYS TYR SEQRES 10 A 300 ASP GLY CYS ALA GLN GLY VAL PHE GLY VAL ASN MSE ARG SEQRES 11 A 300 THR ASN TRP THR ILE ARG GLY SER PHE ILE ASN GLY ALA SEQRES 12 A 300 CYS GLY SER PRO GLY TYR ASN LEU LYS ASN GLY GLU VAL SEQRES 13 A 300 GLU PHE VAL TYR MSE HIS GLN ILE GLU LEU GLY SER GLY SEQRES 14 A 300 SER HIS VAL GLY SER SER PHE ASP GLY VAL MSE TYR GLY SEQRES 15 A 300 GLY PHE GLU ASP GLN PRO ASN LEU GLN VAL GLU SER ALA SEQRES 16 A 300 ASN GLN MSE LEU THR VAL ASN VAL VAL ALA PHE LEU TYR SEQRES 17 A 300 ALA ALA ILE LEU ASN GLY CYS THR TRP TRP LEU LYS GLY SEQRES 18 A 300 GLU LYS LEU PHE VAL GLU HIS TYR ASN GLU TRP ALA GLN SEQRES 19 A 300 ALA ASN GLY PHE THR ALA MSE ASN GLY GLU ASP ALA PHE SEQRES 20 A 300 SER ILE LEU ALA ALA LYS THR GLY VAL CYS VAL GLU ARG SEQRES 21 A 300 LEU LEU HIS ALA ILE GLN VAL LEU ASN ASN GLY PHE GLY SEQRES 22 A 300 GLY LYS GLN ILE LEU GLY TYR SER SER LEU ASN ASP GLU SEQRES 23 A 300 PHE SER ILE ASN GLU VAL VAL LYS GLN MSE PHE GLY VAL SEQRES 24 A 300 ASN SEQRES 1 B 300 ALA GLY LEU ARG LYS MSE ALA GLN PRO SER GLY PHE VAL SEQRES 2 B 300 GLU LYS CYS VAL VAL ARG VAL CYS TYR GLY ASN THR VAL SEQRES 3 B 300 LEU ASN GLY LEU TRP LEU GLY ASP ILE VAL TYR CYS PRO SEQRES 4 B 300 ARG HIS VAL ILE ALA SER ASN THR THR SER ALA ILE ASP SEQRES 5 B 300 TYR ASP HIS GLU TYR SER ILE MSE ARG LEU HIS ASN PHE SEQRES 6 B 300 SER ILE ILE SER GLY THR ALA PHE LEU GLY VAL VAL GLY SEQRES 7 B 300 ALA THR MSE HIS GLY VAL THR LEU LYS ILE LYS VAL SER SEQRES 8 B 300 GLN THR ASN MSE HIS THR PRO ARG HIS SER PHE ARG THR SEQRES 9 B 300 LEU LYS SER GLY GLU GLY PHE ASN ILE LEU ALA CYS TYR SEQRES 10 B 300 ASP GLY CYS ALA GLN GLY VAL PHE GLY VAL ASN MSE ARG SEQRES 11 B 300 THR ASN TRP THR ILE ARG GLY SER PHE ILE ASN GLY ALA SEQRES 12 B 300 CYS GLY SER PRO GLY TYR ASN LEU LYS ASN GLY GLU VAL SEQRES 13 B 300 GLU PHE VAL TYR MSE HIS GLN ILE GLU LEU GLY SER GLY SEQRES 14 B 300 SER HIS VAL GLY SER SER PHE ASP GLY VAL MSE TYR GLY SEQRES 15 B 300 GLY PHE GLU ASP GLN PRO ASN LEU GLN VAL GLU SER ALA SEQRES 16 B 300 ASN GLN MSE LEU THR VAL ASN VAL VAL ALA PHE LEU TYR SEQRES 17 B 300 ALA ALA ILE LEU ASN GLY CYS THR TRP TRP LEU LYS GLY SEQRES 18 B 300 GLU LYS LEU PHE VAL GLU HIS TYR ASN GLU TRP ALA GLN SEQRES 19 B 300 ALA ASN GLY PHE THR ALA MSE ASN GLY GLU ASP ALA PHE SEQRES 20 B 300 SER ILE LEU ALA ALA LYS THR GLY VAL CYS VAL GLU ARG SEQRES 21 B 300 LEU LEU HIS ALA ILE GLN VAL LEU ASN ASN GLY PHE GLY SEQRES 22 B 300 GLY LYS GLN ILE LEU GLY TYR SER SER LEU ASN ASP GLU SEQRES 23 B 300 PHE SER ILE ASN GLU VAL VAL LYS GLN MSE PHE GLY VAL SEQRES 24 B 300 ASN MODRES 1P9S MSE A 6 MET SELENOMETHIONINE MODRES 1P9S MSE A 60 MET SELENOMETHIONINE MODRES 1P9S MSE A 81 MET SELENOMETHIONINE MODRES 1P9S MSE A 95 MET SELENOMETHIONINE MODRES 1P9S MSE A 129 MET SELENOMETHIONINE MODRES 1P9S MSE A 161 MET SELENOMETHIONINE MODRES 1P9S MSE A 180 MET SELENOMETHIONINE MODRES 1P9S MSE A 198 MET SELENOMETHIONINE MODRES 1P9S MSE A 241 MET SELENOMETHIONINE MODRES 1P9S MSE A 296 MET SELENOMETHIONINE MODRES 1P9S MSE B 6 MET SELENOMETHIONINE MODRES 1P9S MSE B 60 MET SELENOMETHIONINE MODRES 1P9S MSE B 81 MET SELENOMETHIONINE MODRES 1P9S MSE B 95 MET SELENOMETHIONINE MODRES 1P9S MSE B 129 MET SELENOMETHIONINE MODRES 1P9S MSE B 161 MET SELENOMETHIONINE MODRES 1P9S MSE B 180 MET SELENOMETHIONINE MODRES 1P9S MSE B 198 MET SELENOMETHIONINE MODRES 1P9S MSE B 241 MET SELENOMETHIONINE MODRES 1P9S MSE B 296 MET SELENOMETHIONINE HET MSE A 6 8 HET MSE A 60 8 HET MSE A 81 8 HET MSE A 95 8 HET MSE A 129 8 HET MSE A 161 8 HET MSE A 180 8 HET MSE A 198 8 HET MSE A 241 8 HET MSE A 296 8 HET MSE B 6 8 HET MSE B 60 8 HET MSE B 81 8 HET MSE B 95 8 HET MSE B 129 8 HET MSE B 161 8 HET MSE B 180 8 HET MSE B 198 8 HET MSE B 241 8 HET MSE B 296 8 HET DIO A 301 6 HET DIO B 301 6 HETNAM MSE SELENOMETHIONINE HETNAM DIO 1,4-DIETHYLENE DIOXIDE FORMUL 1 MSE 20(C5 H11 N O2 SE) FORMUL 3 DIO 2(C4 H8 O2) FORMUL 5 HOH *32(H2 O) HELIX 1 1 SER A 10 LYS A 15 1 6 HELIX 2 2 HIS A 41 ALA A 44 5 4 HELIX 3 3 ASP A 52 ILE A 59 1 8 HELIX 4 4 ARG A 61 HIS A 63 5 3 HELIX 5 5 MSE A 180 PHE A 184 5 5 HELIX 6 6 LEU A 199 ASN A 213 1 15 HELIX 7 7 PHE A 225 GLN A 234 1 10 HELIX 8 8 GLY A 243 PHE A 247 5 5 HELIX 9 9 SER A 248 LYS A 253 1 6 HELIX 10 10 CYS A 257 ASN A 270 1 14 HELIX 11 11 SER A 288 GLY A 298 1 11 HELIX 12 12 SER B 10 LYS B 15 1 6 HELIX 13 13 HIS B 41 ALA B 44 5 4 HELIX 14 14 ASP B 52 ILE B 59 1 8 HELIX 15 15 ARG B 61 HIS B 63 5 3 HELIX 16 16 MSE B 180 PHE B 184 5 5 HELIX 17 17 LEU B 199 ASN B 213 1 15 HELIX 18 18 PHE B 225 GLY B 237 1 13 HELIX 19 19 GLY B 243 PHE B 247 5 5 HELIX 20 20 SER B 248 LYS B 253 1 6 HELIX 21 21 CYS B 257 ASN B 269 1 13 HELIX 22 22 SER B 288 GLY B 298 1 11 SHEET 1 A 7 ALA A 72 LEU A 74 0 SHEET 2 A 7 PHE A 65 SER A 69 -1 N SER A 69 O ALA A 72 SHEET 3 A 7 VAL A 17 TYR A 22 -1 N CYS A 21 O SER A 66 SHEET 4 A 7 THR A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 A 7 ILE A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 A 7 THR A 85 VAL A 90 -1 O ILE A 88 N VAL A 36 SHEET 7 A 7 VAL A 76 HIS A 82 -1 N THR A 80 O LYS A 87 SHEET 1 B 5 HIS A 100 PHE A 102 0 SHEET 2 B 5 GLU A 155 GLU A 165 1 O PHE A 158 N SER A 101 SHEET 3 B 5 PRO A 147 LYS A 152 -1 N ASN A 150 O GLU A 157 SHEET 4 B 5 GLY A 110 CYS A 116 -1 N ASN A 112 O TYR A 149 SHEET 5 B 5 ALA A 121 ASN A 128 -1 O VAL A 127 N PHE A 111 SHEET 1 C 3 HIS A 100 PHE A 102 0 SHEET 2 C 3 GLU A 155 GLU A 165 1 O PHE A 158 N SER A 101 SHEET 3 C 3 HIS A 171 SER A 174 -1 O VAL A 172 N ILE A 164 SHEET 1 D 7 ALA B 72 LEU B 74 0 SHEET 2 D 7 PHE B 65 SER B 69 -1 N SER B 69 O ALA B 72 SHEET 3 D 7 VAL B 17 TYR B 22 -1 N CYS B 21 O SER B 66 SHEET 4 D 7 THR B 25 LEU B 32 -1 O GLY B 29 N VAL B 18 SHEET 5 D 7 ILE B 35 PRO B 39 -1 O TYR B 37 N LEU B 30 SHEET 6 D 7 THR B 85 VAL B 90 -1 O LEU B 86 N CYS B 38 SHEET 7 D 7 VAL B 76 HIS B 82 -1 N THR B 80 O LYS B 87 SHEET 1 E 5 HIS B 100 PHE B 102 0 SHEET 2 E 5 GLU B 155 GLU B 165 1 O PHE B 158 N SER B 101 SHEET 3 E 5 PRO B 147 LYS B 152 -1 N ASN B 150 O GLU B 157 SHEET 4 E 5 GLY B 110 CYS B 116 -1 N ASN B 112 O TYR B 149 SHEET 5 E 5 ALA B 121 ASN B 128 -1 O PHE B 125 N ILE B 113 SHEET 1 F 3 HIS B 100 PHE B 102 0 SHEET 2 F 3 GLU B 155 GLU B 165 1 O PHE B 158 N SER B 101 SHEET 3 F 3 HIS B 171 SER B 174 -1 O VAL B 172 N ILE B 164 LINK C LYS A 5 N MSE A 6 1555 1555 1.32 LINK C MSE A 6 N ALA A 7 1555 1555 1.32 LINK C ILE A 59 N MSE A 60 1555 1555 1.31 LINK C MSE A 60 N ARG A 61 1555 1555 1.35 LINK C THR A 80 N MSE A 81 1555 1555 1.32 LINK C MSE A 81 N HIS A 82 1555 1555 1.33 LINK C ASN A 94 N MSE A 95 1555 1555 1.31 LINK C MSE A 95 N HIS A 96 1555 1555 1.33 LINK C ASN A 128 N MSE A 129 1555 1555 1.33 LINK C MSE A 129 N ARG A 130 1555 1555 1.33 LINK C TYR A 160 N MSE A 161 1555 1555 1.31 LINK C MSE A 161 N HIS A 162 1555 1555 1.31 LINK C VAL A 179 N MSE A 180 1555 1555 1.32 LINK C MSE A 180 N TYR A 181 1555 1555 1.33 LINK C GLN A 197 N MSE A 198 1555 1555 1.33 LINK C MSE A 198 N LEU A 199 1555 1555 1.34 LINK C ALA A 240 N MSE A 241 1555 1555 1.33 LINK C MSE A 241 N ASN A 242 1555 1555 1.31 LINK C GLN A 295 N MSE A 296 1555 1555 1.33 LINK C MSE A 296 N PHE A 297 1555 1555 1.33 LINK C LYS B 5 N MSE B 6 1555 1555 1.33 LINK C MSE B 6 N ALA B 7 1555 1555 1.32 LINK C ILE B 59 N MSE B 60 1555 1555 1.33 LINK C MSE B 60 N ARG B 61 1555 1555 1.33 LINK C THR B 80 N MSE B 81 1555 1555 1.34 LINK C MSE B 81 N HIS B 82 1555 1555 1.32 LINK C ASN B 94 N MSE B 95 1555 1555 1.32 LINK C MSE B 95 N HIS B 96 1555 1555 1.32 LINK C ASN B 128 N MSE B 129 1555 1555 1.32 LINK C MSE B 129 N ARG B 130 1555 1555 1.30 LINK C TYR B 160 N MSE B 161 1555 1555 1.31 LINK C MSE B 161 N HIS B 162 1555 1555 1.32 LINK C VAL B 179 N MSE B 180 1555 1555 1.31 LINK C MSE B 180 N TYR B 181 1555 1555 1.32 LINK C GLN B 197 N MSE B 198 1555 1555 1.33 LINK C MSE B 198 N LEU B 199 1555 1555 1.33 LINK C ALA B 240 N MSE B 241 1555 1555 1.33 LINK C MSE B 241 N ASN B 242 1555 1555 1.32 LINK C GLN B 295 N MSE B 296 1555 1555 1.33 LINK C MSE B 296 N PHE B 297 1555 1555 1.35 SITE 1 AC1 3 HIS A 41 THR A 47 ASP A 186 SITE 1 AC2 1 GLN B 187 CRYST1 53.356 76.240 73.477 90.00 103.70 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018742 0.000000 0.004569 0.00000 SCALE2 0.000000 0.013116 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014008 0.00000